Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Macsen Drugs is an Indian pharmaceutical company and a division of the Macsen Group, specializing in the manufacture of high-purity Active Pharmaceutical Ingredients (APIs), specialty dyes, and laboratory reagents. The company is globally recognized for its production of Methylene Blue (Methylthioninium Chloride) meeting USP, EP, and BP standards. Macsen Drugs operates state-of-the-art manufacturing facilities that cater to the healthcare, diagnostic, and research sectors. Their product portfolio includes various diagnostic dyes like Fluorescein Sodium and Rose Bengal, as well as specialty chemicals for pharmaceutical applications. The company focuses on providing high-quality chemical synthesis and contract manufacturing services to global markets. They maintain a strong emphasis on regulatory compliance and quality control to serve international pharmaceutical clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Macsen Drugs.